Now that the Environmental Protection Agency has said it will evaluate chemicals according to their risk factors in an effort to get new products into the market, several environmental groups have said they are suing the agency.

At a time when the U.S. needs unity and bold reforms, American businesses must be partners in building the future. While the business community has diverse interests, every company should agree on basic policy priorities if we want to be globally competitive.

One of Maryland's largest drug manufacturers is suing the federal government to fend off competition on one of its key drugs, saying its right to exclusively sell the medication should continue an additional three years.

Over 100,000 migrants have entered Europe by sea to date in 2017, according to estimates by the International Organization of Migration.

As city infrastructures age, organizations will increasingly face the threat of higher stormwater fees.

A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug.

Organizations in the United Kingdom could be fined up to £17m ($22.06m), or 4 percent of their global turnover, for having poor cybersecurity under proposed new laws.

Let's just say it plainly: The United States needs more low-skilled immigrants.